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Abstract
Background: PCR has the potential to detect and precisely quantify specific DNA sequences, but
it is not yet often used as a fully quantitative method. A number of data collection and processing
strategies have been described for the implementation of quantitative PCR. However, they can be
experimentally cumbersome, their relative performances have not been evaluated systematically,
and they often remain poorly validated statistically and/or experimentally. In this study, we
evaluated the performance of known methods, and compared them with newly developed data
processing strategies in terms of resolution, precision and robustness.
Results: Our results indicate that simple methods that do not rely on the estimation of the
efficiency of the PCR amplification may provide reproducible and sensitive data, but that they do
not quantify DNA with precision. Other evaluated methods based on sigmoidal or exponential
curve fitting were generally of both poor resolution and precision. A statistical analysis of the
parameters that influence efficiency indicated that it depends mostly on the selected amplicon and
to a lesser extent on the particular biological sample analyzed. Thus, we devised various strategies
based on individual or averaged efficiency values, which were used to assess the regulated
expression of several genes in response to a growth factor.
Conclusion: Overall, qPCR data analysis methods differ significantly in their performance, and this
analysis identifies methods that provide DNA quantification estimates of high precision, robustness
and reliability. These methods allow reliable estimations of relative expression ratio of two-fold or
higher, and our analysis provides an estimation of the number of biological samples that have to be
analyzed to achieve a given precision.
Background
Quantitative PCR is used widely to detect and quantify
specific DNA sequences in scientific fields that range from
fundamental biology to biotechnology and forensic sci-
ences. For instance, microarray and other genomic
approaches require fast and reliable validation of small
differences in DNA amounts in biological samples with
high throughput methods such as quantitative PCR. How-
ever, there is currently a gap between the analysis of the
mathematical and statistical basis of quantitative PCR and
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its actual implementation by experimental laboratory
users [1]. While qPCR has been the object of probabilistic
mathematical modelling, these methods have not often
been employed for the treatment of actual measurements.
Therefore, the validity of the assumptions or simplifica-
tions on which these models are based is often unclear. At
the other extreme, the treatment of laboratory measure-
ments is often fairly empirical in nature, and the validity
or reproducibility of the assay remains usually poorly
characterized from an experimental and/or theoretical
basis. Thus, practical qPCR methods usually do not allow
mathematically validated measurements, nor the determi-
nation of the statistical degree of confidence of the derived
conclusions. Consequently qPCR results have been ques-
tioned [2,3], with the consequence that semi-quantitative
methods (e.g. end-point PCR) remain widely used.
Quantitative PCR amplifications performed in the pres-
ence of a DNA-binding fluorescent dye are typically repre-
sented in the form of a plot as shown in Figure 1A, where
the measured fluorescence is represented as a function of
the PCR cycle number. An assumption that is common to
all qPCR methods is that the fluorescence is directly corre-
lated to the amount of double stranded DNA present in
the amplification reaction [4]. The amplification curves
are sigmoid shaped and can be split into three phases.
Phase I (Figure 1A) represents the lag phase in which no
amplification can be detected over the background fluo-
rescence and statistical noise. This phase is used to evalu-
ate the baseline fluorescent "noise". Phase II corresponds
to the early cycles at which detectable fluorescence levels
start to build up following an exponential behaviour
described by the equation inserted in Figure 1A. On a log
scale graph, this corresponds to the linear phase, illustrat-
ing the exponential dynamic of the PCR amplification
(Figure 1B). During the later phase of the reaction, or
phase III, the DNA concentration no longer increases
exponentially and it finally reaches a plateau. This is clas-
sically attributed to the fact that one or more of the reac-
tants become limiting or to the inhibition of
amplification by the accumulation of the PCR product
itself [5].
In a perfectly efficient PCR reaction, the amount or copy
number of DNA molecules would double at each cycle
but, due to a number of factors, this is rarely the case in
experimental conditions. Therefore the PCR efficiency can
range between 2, corresponding to the doubling of the
DNA concentration at each cycle, to a value of 1, if no
amplification occurs (Eq. 1 in methods). Furthermore, the
efficiency of DNA amplification is not constant through-
out the entire PCR reaction. The efficiency value cannot be
measured during phase I, but it may be suboptimal during
the first cycles because of the low concentration of the
DNA template and/or sampling errors linked to the sto-
chastic process by which the amplification enzymes may
replicate only part of the available DNA molecules [6].
Quantitative PCR is used under the assumption that these
stochastic processes are the same for all amplifications,
which may be statistically correct for N0 values that are
large enough so that sampling errors become negligible
[7]. The efficiency reaches a more or less constant and
maximal value that may approach 2 in the exponential
amplification of phase II, and it finally drops to a value of
1 during phase III. This implies that any appropriate ana-
lytical method should focus on phase II of the amplifica-
tion where the amplification kinetic is exponential.
Therefore, the first step in any qPCR analysis is the identi-
fication of phase II, which is more conveniently per-
formed when data are represented on a log scale (Figure
1B).
Another assumption of qPCR is that the quantity of PCR
product in the exponential phase is proportional to the
initial amount of target DNA. This is exploited by choos-
ing arbitrarily a fluorescence threshold with the condition
that it lies within the exponential phase of the reaction.
When fluorescence crosses this value, the cycle is termed
the "Threshold cycle" (Ct) or "Crossing Point", and the
higher the Ct, the smaller the initial amount of DNA. This
is illustrated in Figure 1B, which displays qPCR amplifica-
tions performed on serial dilutions of a cDNA sample.
One of the first and simple methods to process qPCR data
remains a set of calculations based solely on Ct values and
is currently known as the ΔCt method [8,9]. However, as
such, this method assumes that all amplification efficien-
cies are equal to 2 or at least equal between all reactions.
Therefore it does not take into consideration possible var-
iations of amplification efficiencies from one sequence or
sample to the other. Thus, the ΔCt method may not accu-
rately estimate relative DNA amounts from one condition
or one sequence to the other. Consequently, other meth-
ods of data processing have been developed to estimate
the efficiency of individual PCR amplifications [10-13].
Alternatively, amplification curves can be directly fitted
with sigmoid [14] or exponential functions (Methods sec-
tion, Eq. 6 and Eq. 8) in order to derive the original
amount of template DNA (Eq. 7 and Eq. 9).
Methods to estimate amplification efficiency can be
grouped in two approaches, both of which rely on the log-
linearization of the amplification plot. The most com-
monly used method requires generating serial dilutions of
a given sample and performing multiple PCR reactions on
each dilution [10,12]. The Ct values are then plotted ver-
sus the log of the dilution (Figure 2A) and a linear regres-
sion is performed (Eq. 4) from which the mean efficiency
can be derived (Eq. 5). As stated above, this approach is
only valid if the Ct values are measured from the exponen-BMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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tial phase of the PCR reaction and if the efficiency is iden-
tical between amplifications.
The other method currently used to measure efficiency is
based on Eq. 3, which associates an efficiency value with
each PCR reaction [12]. This approach has been auto-
mated in different programs [15], one of which, termed
LinReg PCR [13], was used in this study. LinReg identify
the exponential phase of the reaction by plotting the fluo-
rescence on a log scale (Figure 2B). Then a linear regres-
sion is performed, leading to the estimation of the
efficiency of each PCR reaction.
None of the current qPCR data treatment methods is in
fact fully assumption-free, and their statistical reliability
are often poorly characterized. In this study, we evaluated
whether known mathematical treatment methods may
estimate the amount of DNA in biological samples with
precision and reliability. This led to the development of
new mathematical data treatment methods, which were
also evaluated. Finally, experimental measurements were
subjected to a statistical analysis, in order to determine the
size of the data set required to achieve significant conclu-
sions. Overall, our results indicate that current qPCR data
analysis methods are often unreliable and/or unprecise.
This analysis identifies novels strategies that provide DNA
quantification estimates of high precision, robustness and
reliability.
Results
Quantitative PCR usually relies on the comparison of dis-
tinct samples, for instance the comparison of a biological
sample with a standard curve of known initial concentra-
tion, when absolute quantification is required [16], or the
comparison of the expression of a gene to an internal
standard when relative expression is needed. The equation
inserted in Figure 1B is used to calculate the ratio of initial
target DNA of both samples (Eq. 2). The error on the nor-
malized ratio depends on the error on the Ct and the error
on the efficiency, and it can be estimated from Eq. 11.
However, the range and relative importance of the various
components, and the origin of the error on practical meas-
urements remain poorly characterized.
To evaluate the reproducibility of Ct measurements and
their associated error, we generated a set of 144 PCR reac-
tion conditions corresponding to various target DNA,
cDNA samples and dilutions (see Additional file 1 for a
description of targeted genes and amplicons). Each of
these 144 reaction conditions was replicated by perform-
ing 4 or 5 independent PCR amplifications. This yielded a
complete dataset of 704 amplification reactions which
Representations of real-time PCR amplification curves Figure 1
Representations of real-time PCR amplification curves. The three phases of the amplification reaction are shown 
either on a linear scale (panel A) or on a semi-log scale (panel B). Panel A represents a typical amplification curve, while panel 
B depicts amplification curves generated from serial dilutions of the same sample, either undiluted or diluted 10- or 1000-fold 
(indicated as 1, 0.1 or 0.001, respectively). During the lag phase (phase I), the fluorescence resulting from DNA amplification is 
undetectable above noise fluorescence in part A, while in part B, some data points take negative values and are not repre-
sented. This phase is used to evaluate the baseline "noise" of the PCR amplification. Exponential amplification of the DNA is 
detected in phase II (cycles 16 to 23, panel A). This phase of the amplification corresponds to the linear portion of the curve in 
panel B (closed circles). A threshold value is usually set by the user to cross the log linear portion of the curve, defining the 
threshold cycle value (Ct). Phase II is followed by a linear or plateau phase as reactants become exhausted (phase III). The 
inserted equations describe the dynamic of the amplification during phase II.BMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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collection of raw data is given in additional file 2. Individ-
ual Ct values corresponding to each reaction conditions
were averaged, providing a set of 144 Ct values and their
associated errors. The standard deviation (SD) shows an
increase of the error with higher Ct values, with SD values
smaller than 0.2 for Ct up to 30 cycles, and spreading over
0.8 for Ct higher than 30 (Additional File 3). Thus, all rep-
licates with SD above 0.4 were excluded, which corre-
sponds to some of the reactions with Ct above 30 in this
study. We conclude that Ct between 15 and 30 can be
reproducibly measured leading to a dynamic range of 105,
which is within the 4 to 8 logs dynamic range reported in
other studies [17]. In these conditions, Ct value determi-
nation is unlikely to be a major source of error when cal-
culating normalized ratio of expression. Thus, we then
focused on the estimation of efficiency.
Estimation of the efficiency of a PCR reaction
We compared estimates of the efficiency obtained from
two distinct methods: the generally used serial dilution
Measurement of the efficiency of a PCR reaction Figure 2
Measurement of the efficiency of a PCR reaction. A: Estimation of the efficiency using the Serial dilution (SerDil) 
method. Five dilutions of a cDNA sample were amplified using the fibronectin (FN) amplicon. Each dilution was analyzed with 
five replicates PCR reactions and each data point represents one Ct value determined as in Figure 1B. Linear regression param-
eters and calculation of the efficiency value are shown in the inserted textbox. B: Screenshot of the LinReg PCR program anal-
ysis window, which allows the estimation of the efficiency value from each set of amplification curves [13]. Data correspond to 
one of the reactions performed from the undiluted sample used in part A. C: Comparison of the efficiency values obtained 
using the Serial dilution and LinReg methods for the FN amplicon. Efficiency values were determined from four independent 
cDNA samples using the Serial Dilution method as in part A, or the LinReg method as in part B. For each sample, efficiency 
value were either determined from one linear regression performed on 24 reactions altogether (Serdil) and error bars calcu-
lated from the standard deviation on the slope as determined from the linear regression method or the individual efficiency val-
ues determined from each of the same 24 PCR reactions (LinReg) were averaged, and error bars represent the standard 
deviation on the set of values.
A
C
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(Figure 2A) and the alternative LinReg method (Figure
2B). With our experimental setup, estimation of the effi-
ciency with the serial dilution method requires a set of 24
PCR reactions for a given sample and a given amplicon,
using serially diluted template DNA. The efficiency
obtained was compared to the average efficiency esti-
mated from each of the reactions with the LinReg method.
Efficiency estimates are comparable when looking at val-
ues given in Figure 2A and 2B, but they differed when
comparing the efficiencies obtained from one of the four
DNA samples (Figure 2C). Thus, we questioned whether
the two methods provide statistically similar measures of
efficiency, and whether they display similar reproducibil-
ity.
The statistical equivalence of the LinReg and serial dilu-
tion methods was assessed using an analysis of variance
(ANOVA, Table 1), which indicated that the efficiency
averages are not significantly different between the two
methods except for one amplicon, corresponding to the
Connective Tissue Growth Factor (CTGF) cDNA (p  <
0.05). This may be linked to the fact that this gene is
expressed at very low levels and because of the reduced
size of the data set, as some data had to be discarded
because signal was undetectable (Ct ≥ 40). Also, some
estimates were taken from PCR displaying Ct values in the
35 – 40 range. Thus, statistically significant difference
between the two methods may likely result from the
smaller dataset and/or the use of reactions with Ct values
outside of the optimal range. The reproducibility of the
LinReg method appears to be overall higher than that of
the serial dilution method (Figure 2C). An F-test per-
formed over the averaged variance of each method indi-
cated that for each set of primer, the difference between
the variance of the serial dilution and LinReg methods is
very significant, with p-values well below 0.001 (Table 1).
Overall, we conclude that the two methods display com-
parable accuracy in measuring efficiency values of a set of
reactions. Statistically, this implies that these methods
provide acceptable estimator of the efficiency. However,
LinReg appears to be more robust, as lower variances were
obtained. Furthermore, LinReg can be mathematically jus-
tified when the PCR amplification is in the exponential
phase (see Additional File 4).
Experimental parameters influencing efficiency 
determination
Next, we wished to determine which of the experimental
variables may affect the precision of the estimation of effi-
ciency. This was evaluated on the complete set of quanti-
tative PCR reactions. Figure 3 shows the distribution of
the efficiencies measured for all reactions. Efficiencies
ranged from 1.4 to 2.15 with a peak value around 1.85.
Theoretically, efficiencies can only take values between 1
and 2, and therefore they are expected to deviate from a
normal distribution, as indicated by a Kolmogorov-
Smirnoff test (not shown). However, the distribution
appears to be sufficiently symmetrical to be considered
normal, such that classical statistical tests can be validly
performed.
First, we determined if single PCR parameters (amplicons,
cDNA samples, Ct value, etc.) may influence the efficiency
value by performing a multiple ANOVA test on all values.
The first four entries of Table 2 indicate that the efficiency
is most dependent upon the amplicon and relatively less
on cDNA samples, as indicated by high F values, both of
these effects being highly significant (p < 0.001). How-
ever, efficiency was not found to depend on the Ct nor the
dilution, showing that efficiency is solely dependent on
the kinetic of the PCR reaction in the exponential phase
and not on the initial condition (i.e. the amount of initial
template). Possible interactions between pairs of parame-
ters that affect the efficiency (co-dependence) were also
assessed, showing that amplicon-dependent effects on the
efficiency are modulated by the type of sample. Interest-
ingly, while the dilution is not significantly influencing
the efficiency, it can significantly modulate the effect of
the primers and the samples. This is consistent with the
presence of inhibitor(s) in samples that would affect PCR
reactions at the highest concentrations. For instance, salts
or competing genomic DNA would be expected inhibit
the interaction of primers and target DNAs differently.
None of the other co-dependences were of any signifi-
cance. Since the Ct  and dilution are not independent
parameters, two ANOVA test were run excluding either
one. The Ct did not have a significant effect on the effi-
ciency even when the dilution parameter was not taken
into account. On the other hand, the dilution effect was
not affecting efficiency significantly by itself but it modu-
lated the effect of the amplicon. Either way, these results
indicate clearly that the Ct has no direct effect on the effi-
ciency.
Overall, these results indicate that efficiencies are highly
variable among PCR reactions and that the main factor
that defines the efficiency of a reaction is the amplicon.
This is consistent with the empirical knowledge that
primer sequences must be carefully designed in quantita-
tive PCR to avoid non-productive hybridization events
that decrease efficiency, such as primer-dimers or non-
specific hybridizations. Efficiency might also depend
upon the dilution for a minority of the cDNA samples,
indicating that dilute samples should be preferred to
obtain reliable efficiency values.
DNA quantification models
The models we evaluated in this study can fall into two
different groups: being derived from either linear or fromBMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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non-linear fitting methods. Comparison of qPCR data
using models based on non-linear fitting methods (Eq. 6
and Eq. 8) is done simply by calculating the ratio of the
initial amount of target DNA of each amplicon (Eq. 7 and
Eq. 9) as in the first part of Eq. 2. The standard deviation
of the ratio on a pool of replicate is calculated using Eq.
10. Note that in this case, errors resulting from the non-
linear fitting itself are not considered in the analysis.
Linear fitting methods also allow the estimation of the ini-
tial level of fluorescence induced by the target DNA. For
instance, Eq. 3, upon which the LinReg method relies to
determine efficiency, can also be used to determine F0 as
the intercept to the origin of a linear regression of the log
of fluorescence. This figure can then be used to calculate
relative DNA levels (Eq. 2). This calculation method was
termed LRN0.
However, even small errors on the determination of the
efficiency will lead to a great dispersion of N0 values due
to the exponential nature of PCR (Eq. 2). Therefore, we
considered alternative calculation strategies, whereby the
efficiency is averaged over several reactions rather than
using individual values, which should provide more
robust and statistically more coherent estimations. We
therefore evaluated the use of efficiency values calculated
in three different manners.
As the amplicon sequence is the main contributor to the
efficiency, we used the efficiency averaged over all cDNA
samples, dilutions and replicates of a given amplicon, as a
more accurate estimator of the real efficiency than indi-
vidual values. The error on the efficiency is no longer con-
sidered in the calculations of relative DNA concentrations,
thus assuming that the estimator is sufficiently precise so
that errors become negligible. This model is termed below
(PavrgE)Ct.
Alternatively, the small influence of the sample upon the
efficiency was taken into account by averaging the effi-
ciencies obtained for each dilutions and replicates of a
given cDNA sample and a given amplicon. Thus, for a
given cDNA sample and amplicon, one efficiency value is
obtained from 24 PCR reactions. This value is used in fur-
ther calculations, assuming again the average value to be
a sufficiently good estimator of the efficiency so that the
relative error may not be taken into account. This model
was named (SavrgE)Ct.
Finally, we tested a model in which the efficiency is esti-
mated individually for each set of replicated reactions.
This was addressed by averaging the efficiency of each rep-
licates of a given amplicon, cDNA sample and dilution.
This model is referred below as Ect. These three models are
summarized in Table 3.
Distribution of efficiency values in the complete data set Figure 3
Distribution of efficiency values in the complete data 
set. Efficiency of 704 PCR reactions encompassing different 
cDNA samples, primers and dilutions are shown as deter-
mined using the LinReg method, as done in Figure 2B.
Table 1: Comparison between serial dilution and LinReg for the measurement of efficiency
Amplicon Test of equality* Test of variance**
Cav p = 0.24 p < 0.001
CTGF p < 0.001 p < 0.001
Eln p = 1 p < 0.001
FN p = 0.65 p < 0.001
L27 p = 0.8 p < 0.001
Perl p = 1 p < 0.001
PAI-1 p = 0.93 p < 0.001
* Single one-way ANOVA was applied to the complete set of data to assess whether both the Serial dilution and the LinReg methods give similar 
averaged efficiencies (H0: efficiencies are equal, H1: efficiencies are different): a p-value below 0.05 indicates that measured efficiencies are 
significantly different. **F-test assessing whether the variance (error) induced by each method is the same [H0: variances are equal, H1: var(serial 
dilution) > var(LinReg)]: p < 0.001 indicates that the variance obtained with the serial dilution is significantly greater than that of LinReg.BMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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Evaluation of the quantitative PCR calculation models
The dilutions of a given sample form a coherent set of
data, with known concentration relationships between
each dilution. Each calculation model was therefore used
on each dilution series, using the undiluted sample for
normalization. All data can be presented as measured rel-
ative concentrations, the undiluted dilution taking the rel-
ative concentration value of 1, the 10-fold dilution taking
the value of 0.1, the 50-fold dilution a value of 0.02, and
so on. The measured relative concentrations for all dilu-
tions, samples and primers and the associated errors were
calculated using each model from the complete dataset of
704 reactions. For the models giving a direct insight to the
initial N0 values, N0 were averaged for each amplicon and
cDNA sample, and they were plotted in comparison with
the expected concentrations relative to the undiluted sam-
ples (Figure 4). The models were evaluated on three crite-
ria: resolution, precision and robustness.
We defined the resolution as the ability of a model to dis-
criminate between two dilutions. Relative concentrations
were compared pair-wise between adjacent dilutions. Typ-
ically, it can be seen in Figure 4 that models did not give
uniformly coherent results. For instance, models that do
not rely on explicit efficiency values, such as the sigmoid
or exponential models, are unable to discriminate
between the 0.1 and 0.02 relative concentrations, which
shows a lack of resolution in this range of dilutions. The
ΔCt, (PavrgE)Ct  and (SavrgE)Ct  models performed well
under this criterion, allowing easy discrimination of the
10-fold and 50-fold dilutions in this example.
The resolution was statistically evaluated with a coupled
ANOVA-LSD t-test, which is a two step analysis of variance
(ANOVA) coupled to a t-test run under the Least Signifi-
cant Difference method (LSD) [18]. Unsurprisingly, the
ANOVA test indicated that for all models at least one of
the measured concentrations differed significantly from
the others as expected (data not shown). To further assess
if all measured concentrations significantly differ from
one another, or if some are undistinguishable, a coupled
t-test was performed on pairs of adjacent dilutions in a
given serial dilution series. Results are summarized in
Table 4. All models were able to discriminate the undi-
luted condition from the 10-fold dilution (highly signifi-
cant, p < 0.01). The sigmoid and exponential models did
not discriminate further dilutions. The ΔCt, ECt and LRN0
p-value indicate that these models could discriminate the
Table 3: Models for the use of single reaction efficiencies
Grouping of individual efficiencies for average determination
Model Amplicon (7) cDNA (4) Dilutions (5) Replicates (5) Reactions (700)
(PavrgE)Ct * individual pooled pooled pooled 100
(SavrgE)Ct individual individual pooled pooled 25
Ect individual individual individual pooled 5
*Each line indicates how single efficiency values are grouped in each of the calculation models. For instance, the (PavrgE)Ct model line indicates that 
one individual amplicon is chosen out of the 7 available ones, then efficiencies estimated from the different cDNA samples, dilutions and replicates 
are all pooled, leading to the determination of one efficiency value from 100 reactions. In the (SavrgE)Ct model, individual efficiency values are 
calculated for each cDNA sample and each amplicon averaging efficiency values from the 5 replicate reactions performed on the 5 dilutions (25 
values overall).
Table 2: Parameters influencing the efficiency of qPCR reactions.
Parameter Df F-value p-value
Amplicon 6 219.331 <0.001
Sample 10 7.227 <0.001
Ct 1 0.646 0.422
Dilution 4 2.111 0.078
Amplicon:Sample 15 4.525 <0.001
Amplicon:Ct 6 1.957 0.07
Amplicon:Dilution 20 2.576 <0.001
Sample:Ct 10 1.226 0.271
Sample:Dilution 37 1.512 0.029
Ct: Dilution 4 1.872 0.114
Residuals 700
A multiple ANOVA test was performed on efficiencies obtained from 700 reactions. Dependence with amplicon sequence, sample, Ct and dilutions 
were tested as well as all combinations of co-dependence. Df indicates the degree of freedom. The larger the F-value, or the smaller the p value, the 
more significant is the effect of the corresponding parameter.BMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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10-fold from the 50-fold dilution, but not further dilu-
tions. The (SavrgE)Ct and (PavrgE)Ct models were able to
discriminate the 10-fold from the 50-fold dilution and
were at the limit of significance when comparing the 50-
fold with the 100 fold dilutions (significant, p < 0.1).
Finally, none of the models were able to discriminate the
100 fold from the 1000 fold dilution. These comparisons
indicated that (SavrgE)Ct  and (PavrgE)Ct  models per-
formed equally well in this assay, followed by ΔCt, ECt and
LRN0, while the sigmoid or exponential models were of
low resolution. These results also illustrate that more
dilute samples are generally more difficult to discrimi-
nate, as expected from the finding that variance increases
with higher Ct values (Additional File 3).
The precision of a model is defined by its ability to pro-
vide expected relative concentrations of the known dilu-
tions. Again Figure 4 shows that the (PavrgE)Ct  and
(SavrgE)Ct models provide precise relative concentration
values over all dilutions, with the measured relative con-
centrations matching the expected ones. Estimations
obtained by the ΔCt model appear to be less reliable, with
a systematic under-representation of concentrations. This
result is expected since all of our amplicons have efficien-
cies that are below 2 (see Additional File 5).
We statistically evaluated the precision of each model by
plotting the expected relative concentration against the
measured relative concentration averaged from all prim-
ers and samples (Additional File 3). A linear regression
was done on the data obtained from each model and a t-
test was performed to determine if the slope is statistically
different from 1. A low p-value in Table 5 is associated to
a high probability that the slope is different from 1, indic-
ative of a poor correlation between expected and meas-
ured values. As before, the (PavrgE)Ct  and (SavrgE)Ct
models outperformed all other models, being more pre-
cise than the and sigmoid models, the exponential, ΔCt
and LR N0 displaying lowest precision.
Finally, the robustness is related to the variability of the
results obtained from a given model, and it indicates
whether trustable results may be obtained from a small
collection of data. For instance, a model could be very pre-
cise (eg providing a slope of 1) with a large data set, but
the distribution of the points around the regression line
could be very dispersed. Such a model would not be
robust as a small data set would not allow precise meas-
urements. Thus, the robustness of a model was estimated
from the standard deviation of the slope and the related
correlation coefficient of the linear regression (r2), with
higher  r2 values indicating more robust models. Three
models showed high robustness, the ΔCt, (PavrgE)Ct and
(SavrgE)Ct, followed by ECt (Table 5). Overall, only two
calculation models combine high resolution, precision
and robustness, namely the (PavrgE)Ct and the (SavrgE)Ct
Comparison of the different calculation models when applied to samples of known relative concentrations Figure 4
Comparison of the different calculation models when applied to samples of known relative concentrations. 
Each cDNA samples serial dilutions were processed with the indicated models, measured concentration were expressed as 
relative to the undiluted sample. Then results of all amplicons were averaged for a given model.BMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
Page 9 of 16
(page number not for citation purposes)
methods. However, only the slope of the (SavrgE)Ct did
not statistically differ from 1.
Model evaluation on a biological assay of gene expression 
regulation
Usually, experimenters are interested in the difference
between two conditions (with versus without a drug, sane
versus metastatic tissue, etc...) [19-21], for instance to
determine whether the expression of the gene of interest is
induced or repressed upon treatment or between samples.
So the useful figure is the normalized induction ratio (Eq.
13). We set up to use the most promising approaches on
samples of biological interest. NIH-3T3 fibroblastic cells
were incubated with the TGF-β growth factor for 4 hours,
as it is known to induce the expression of a number of
extracellular matrix protein genes. For this experiment, the
CTGF, FN and PAI-1 genes were chosen, for they were
shown to be induced at various levels by the growth factor
in fibroblasts [22,23]. The total mRNA of three independ-
ent biological samples from the induced as well as the
non-induced condition were mixed and processed as
before. The expression levels of these genes were normal-
ized to the ribosomal L27 protein gene expression used as
an invariant mRNA, so as to correct for differences in
mRNA recovery or reverse transcription yield. Following
the results of the previous section, only the (SavrgE)Ct,
(PavrgE)Ct and ΔCt methods were used.
Ten replicate PCR reactions were performed for each con-
dition (induced or non-induced) and normalized expres-
sion values obtained with (SavrgE)Ct (SavrgE)Ct, (PavrgE)Ct
or ΔCt are shown in Figure 5. Fibronectin is expressed at
high levels but it is only moderately induced by the
growth factor (Additional File 1), while PAI-1 and CTGF
have much lower expression levels but higher induction
ratios (Figure 5, top panels). The three methods yielded
consistent results overall. However, the low induction
ratio of the fibronectin gene was statistically significant
with (SavrgE)Ct (p < 0.05) but not with (PavrgE)Ct (0.38)
or ΔCt (p = 0.39).
To assess whether the relative performance of the three
models depends critically on the number of replicate
assays, the analysis was repeated, but taking into account
only the first three values obtained from the set of 10 rep-
licates. Similar results were obtained (Figure 5, bottom
panels), and the small induction of the expression of the
FN gene was again only detected using the (SavrgE)Ct
model. Thus, small differences in gene expression are also
more reliably estimated from this model with a low
number of replicates commensurate with usual experi-
mental procedures.
Dataset size required to achieve statistical significance
In the above example, independent biological samples
were mixed so as to decrease the variability associated
Table 4: Resolution of each calculation model
Relative concentrations ΔCT ECt (Savrg E)Ct (Pavrg E)Ct LR N0 Sigmoid Exponential
t-value p-value t-value p-value t-value p-value t-value p-value t-value p-value t-value p-value t-value p-value
1 – 0.1 122.7 0.000 18.6 0.000 141.7 0.000 141.3 0.000 18.9 0.000 29.1 0.000 18.2 0.000
0.1 – 0.02 7.3 0.000 1.9 0.030 12.6 0.000 12.6 0.000 3.5 0.000 -4.4 N/A 0.8 0.225
0.02 – 0.01 0.7 0.232 0.4 0.360 1.6 0.052 1.6 0.052 0.9 0.190 6.1 0.000 -0.4 N/A
0.01 – 0.001 0.5 0.325 0.3 0.375 1.3 0.105 1.2 0.107 0.5 0.306 0.1 0.478 2.7 0.004
A ANOVA coupled t-test was performed to determine which dilutions are statistically different from one another. The comparison of adjacent 
dilutions are shown. A p-value higher than 0.05 indicate that the model is unable to discriminate between the two adjacent dilutions. N/A stands for 
not available and indicate that the expected higher concentration of the comparison was in fact calculated to be lower from the qPCR results.
Table 5: Precision of each calculation model
Model Slope SD p-value r2
Sigmoid 0.085 1.225 4.4E-12 0.00004
LR N0 1.830 0.621 4.7E-26 0.07441
Exponential 0.707 1.047 0.004 0.00421
ECt 1.103 0.127 1.2E-13 0.40965
ΔCt 0.689 0.013 1.4E-149 0.96041
(Pavrg E)Ct 0.994 0.026 0.021 0.93213
(Savrg E)Ct 0.996 0.027 0.170 0.92419
Expected and measured relative concentrations were plotted and a linear regression was performed (Additional File 3). The slopes values were 
submitted to a t-test to evaluate if they are statistically different from 1, which would indicate a poor correlation between expected and measured 
concentrations. A p-values smaller than 0.05 indicate that the slope is significantly different from 1. Correlation coefficient (r2) values indicate the 
width of the spreading of individual data around the linear regression line. Higher r2 indicate more robust models.BMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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with cell culture and mRNA isolation. Therefore, this
study provides the statistical significance that may be
expected just from the intra-assay variability in the qPCR
process. However, statistical significance will also depend
on the inter-assay, or biological variability. To assess the
statistical significance associated to particular conclusions
on gene expression regulation, replicates of induction
experiments are usually generated and, in most experi-
mental studies, the number of biological replicates is low,
being typically obtained from 3–6 independent biological
samples.
Thus, we wished to determine how many biological repli-
cates may be necessary to obtain statistically reliable
results, depending upon the variability of the assay (Eq.
15). Using the data from the 10 replicates to estimate the
intra-assay variability, we found that the standard devia-
tion is proportional to the induction ratio value (Addi-
tional File 1). This is shown by coefficient of variation
(CV) values being conserved for all induction ratios at a
level just below 15%, irrespective of the calculation
method. Use the set of three replicate assays resulted in
more variable but comparable CV values around or lower
than 15%, which is in agreement with other published
data [17]. However, inter-experiment biological variabil-
ity will be specific to each experimental system. The true
variability of the PCR assay (intra-assay and biological
inter-assay variability) is higher, typically with overall CV
values ranging around 30% to 50% (own unpublished
results and [24]). Another parameter influencing the
number of replicates needed to assess statistical reliability
is the domain (range) of confidence of the measure. This
value is defined as the largest acceptable error on the
measure and it is set arbitrarily by the experimenter. Thus,
setting a domain of 20% indicates that the estimated
induction should fall within 20% of the real value. It fol-
lows that the larger the domain of confidence, the lower
the number of replicates needed.
Table 6 provides the number of independent measure-
ments that is required to achieve a statistically significant
measurement from any given induction ratio. Taking the
minimal theoretical CV of 15%, obtaining an induction
ratio within a domain of 10% of the real value would
Comparison of the (SavrgE)Ct, (PavrgE)Ct and ΔCt methods to quantify gene expression regulation Figure 5
Comparison of the (SavrgE)Ct, (PavrgE)Ct and ΔCt methods to quantify gene expression regulation. cDNAs were 
prepared from RNA extracted from fibroblastic cells induced or not by TGF-β treatment, as described in the Materials and 
methods. Expression as determined from the mRNA levels of the plasminogen activator inhibitor 1 (PAI-1), fibronectin (FN) 
and connective tissue growth factor (CTGF) genes were normalized to those of the ribosomal L27 protein, used as an invariant 
internal reference. Normalized gene expression was calculated using the (SavrgE)Ct, (PavrgE)Ct or the ΔCt methods, as indicated, 
using either the complete set of 10 replicate assays (top histograms), or using just three measurements (first three assays of 
the series, bottom histograms). Error bars represent standard deviations on the normalized ratio. A t-test was performed on 
the normalized gene expression to check whether the expression were statistically different between the induced and the non-
induced state (* = p < 0.05, ** = p < 0.001, # = p > 0.1).BMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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require 9 independent induction measurements. If one
accepts a range of 30%, only one value is expected to be
required. However, considering the biological variation in
a CV value of 50%, and setting a 10% range of confidence,
then 97 independent measurements would be needed to
achieve statistically valid conclusions, which is unpracti-
cal in most cases. One therefore needs to accept a range of
confidence of 50% to pull this value down to a feasible
experimental set of 4 independent biological samples.
Thus, with such settings, qPCR may be reasonably used to
detect induction ratio around 2-fold or higher.
Discussion
The simplicity of producing quantitative PCR data has
overshadowed the difficulty of making a proper analysis
of those data. Although the principle of qPCR is theoreti-
cally well described, analysis of the experimental data can
become very difficult if one is not aware of the different
assumptions that the different models are based on, and
of their resulting limitations. Furthermore, a systematic
evaluation of the relative performance of the models used
for the treatment of experimental measurements and a
description of their statistics are currently lacking. Thus,
no single method has gained a general acceptance in the
community of experimentalists.
In this study, we reviewed the mathematical basis and
assumptions of previously described calculation methods
and evaluated their ability to provide quantitative results
from a practical dataset size. Initially, we first evaluated
previously reported methods and concluded that an esti-
mation of the PCR amplification efficiency is prerequisite
to obtaining precise quantification, in agreement with
other studies [6,25-28]. However, we found that the error
associated with the determination of the efficiency value
may render measurements of little statistical significance.
Therefore, in addition to evaluating previously proposed
general data processing strategies (ΔCt, ECt), we generated
new methods or variations (exponential fit, (PavrgE)Ct and
(SavrgE)Ct, LRN0), and we compared all approaches with
datasets generated from several independent genes and
biological conditions.
Estimation of the PCR efficiency
The classical serial dilution and the newer LinReg meth-
ods used for measuring efficiency were both found to pro-
vide good estimator values of the efficiency, as based on
an ANOVA analysis. However, the efficiency values were
not uniformly equivalent when comparing both methods,
as they were significantly different for some of the assay
genes. The larger variability of efficiency values obtained
with the classical serial dilution method with all test genes
led us to conclude that it was not an estimator as accurate
as LinReg. In addition, while both methods are very sensi-
tive to changes of the concentration of potential inhibi-
tors present in the sample upon serial dilutions, the serial
dilution method does not allow the assessment of such
effect while LinReg does [13]. Furthermore, LinReg
requires much less PCR reactions to determine efficiency
and is faster to implement. Results presented here show
that consistent efficiency estimates can be obtained for a
variety of target genes with this method.
Factors affecting the efficiency value
The large variation associated with efficiency estimations,
even from duplicate analysis of the same sample, led us to
analyse the determinants of this variability. This analysis
showed that efficiency is strongly dependent on the
primer sequence. These results are in accordance with the
common knowledge that careful design of the PCR prim-
ers is required to obtain useable PCR amplifications data
and high efficiency values [29,30]. Dependence of the effi-
ciency on the primer sequences may be explained by inter-
fering reactions that would decrease PCR efficiency
depending on the primer pair, such as formation of
primer dimers, intra-strand hybridization or unspecific
hybridization to other cDNA sequences.
Assay of independent biological samples was also found
to significantly affect the efficiency, but to a lesser extent.
Table 6: Number of measurement replicates needed to reach statistical significance
Range (%)
CV value (%) 10 20 30 40 50
1 5 93111
3 0 3 5 9432
40 62 16 7 4 3
50 97 25 11 7 4
The number of replicates needed to reach statistical significance depends on the reproducibility of the measures (CV) and the range of confidence 
one wants to achieve (the real value being within the indicated percentile from the estimator qPCR value). The confidence level α was set to 0.05 
(z0.975 = 1.960).BMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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Others have observed that sample to sample variations
may predominate, which may reflect differences in sam-
ple preparation methods and/or distinct biological sys-
tems [31]. These effects can be related to cell-specific
contaminants and/or to exogenous contaminants intro-
duced during sample preparation that may interfere with
the assay [29,30]. Indeed, use of undiluted reverse tran-
scriptase reaction samples was found to decrease effi-
ciency values significantly and to increase variability
between samples (YK, unpublished results). However,
such effects should be alleviated in dilute samples such as
those used here, and we found that the average efficiency
value does not correlate significantly with the dilution fac-
tor, at least for the dilution range used in this study. This
indicates that in the conditions used, the variation associ-
ated with the samples does not result primarily from
chemical contaminants that would interfere directly with
the DNA elongation reactions. Interestingly, the efficiency
values are not dependent on the measured Ct, which
reflects both the initial DNA concentration in the extract
and the dilution ratio, further strengthening the conclu-
sion that the concentration of impurities in the sample or
the initial N0 concentration are not the main determinants
of the PCR efficiency. Therefore, the distinct efficiencies
obtained from independent samples should also reflect
other properties of the sample that are not affected by
dilution.
For instance, the presence of damaged or nicked cDNA in
the sample has been shown to affect PCR efficiency [32].
This may result in the linear amplification of shorter DNA
fragments, as opposed to the exponential amplification of
correct length DNA from the undamaged cDNA, and in a
decrease of available nucleotides around the Ct cycle
affecting the observed efficiency. In addition, if linearly
amplified truncated DNA strands still contribute a signif-
icant proportion of fluorescence at the Ct, increase in flu-
orescence would reflect both the efficiency of the
amplification of DNA template of correct length (expo-
nential amplification) and a lower efficiency value corre-
sponding to the amplification of shorter molecules (linear
amplification). Similarly, the presence of incomplete
elongated cDNAs, base hydrolysis or chemical oxidation
also impairs polymerase progression, leading to the unidi-
rectional amplification of shorter products that could also
decrease PCR efficiency [33]. Variations in the ratio of
non-functional to functional templates would thus
explain changes in the apparent amplification efficiency
from one sample to the next irrespective of the dilution.
Evaluation of various qPCR calculation models
Models were evaluated under 3 criteria: resolution, preci-
sion and robustness. Resolution is a measure of the ability
of a model to discriminate two successive dilutions. Preci-
sion is the correlation between measured and expected
concentrations. Finally the robustness is a measure of the
dispersion of the measured values around the expected
concentrations.
Overall, two calculation models stand out: the (PavrgE)Ct
and the (SavrgE)Ct models, as these are among the top
scoring methods on the three evaluation criteria. How-
ever, (PavrgE)Ct shows a small but statistically significant
bias when comparing the obtained and expected values,
suggesting that it slightly underestimates the more dilute
DNA concentrations. In contrast, results calculated from
(SavrgE)Ct cannot be statistically distinguished from the
expected data and are thus of higher precision. In addi-
tion, (SavrgE)Ct  displayed a higher resolution than
(PavrgE)Ct when assessed on biological samples. These
models are followed by ECt, which is of lower but consist-
ent resolution, robustness and precision.
The ΔCt model stands apart from all other models. Firstly,
because it is the first model ever having being used in
automated quantitative PCR, but also because of its prop-
erties as analyzed here. As expected, this model very signif-
icantly underestimates actual DNA concentrations, with a
clear statistical indication that it is of low precision. How-
ever, it mediates the highest robustness value of all meth-
ods. Thus, this model is quite unprecise, but it yields very
reproducible results. The ΔCt model may therefore be of
interest for screening purposes, as its strong robustness
and ease of use makes it ideal to analyze large collections
of biological samples with few replicates, for instance to
screen for changes in the expression a large number of
genes, after which a finer analysis on the genes displaying
interesting expression profiles may be performed using
the (SavrgE)Ct or (PavrgE)Ct models. It must be empha-
sized here that if PCR is performed with carefully designed
and optimized primers that yield high efficiency [34],
then the ΔCt model would be the best model of all. Unfor-
tunately obtaining such primers is labour-intensive and
costly, when not impossible.
Finally the sigmoid, exponential and LR N0 models ana-
lysed here are least suitable for quantitative PCR analysis
as they have a low resolution and/or precision, and
because they display very low robustness. Improved ver-
sions of the original sigmoid model [14] used here has
recently been reported [35,36], which should result in
increased robustness. In parallel to the sigmoid fitting
methods analyzed here, we also evaluated several other
sigmoid fitting algorithms, which performances were
either similar or even less accurate than the method used
here (unpublished data). This observation is in accord-
ance with Feller's conclusions that different S-shaped
curves can be similarly fitted with various sigmoid models
[37], each providing distinct N0 value from its own set of
parameters. Thus sigmoid fit methods such as the logisticBMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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model used above are purely descriptive, and biological
conclusions drawn from the fitting parameters may be
unreliable.
Perhaps surprisingly, the exponential fitting method also
scored with very low performance, despite the expected
exponential nature of DNA amplification by PCR. This
may result in part from poorly characterized borders of
the exponential phase, leading to the fitting of experimen-
tal points that are already in phase III. Alternatively it may
result from the possible non-exponential nature of PCR
that would result from both linear and exponential ampli-
fication, as discussed above. The exponential and sigmoid
methods are based on descriptive models. They often pro-
duce outlier N0 values, suggesting that they might not be
accurate mathematical models of the PCR process [37].
Furthermore, these models take into account the early
PCR cycles that are swamped by fluorescence noise, lead-
ing to a large variation in the calculated N0. An additional
explanation for the inadequate performance of the sig-
moid, exponential, and LR N0 models is that they do not
explicitly determine the efficiency value, and therefore
cannot make use of average efficiencies obtained from
several independent measurements. These observations
thus support the conclusion that the determination of a
precise efficiency value is paramount to the success of
qPCR, and it provides a rational explanation for this phe-
nomenon.
Conclusion
Overall, three models stand out and may be used prefera-
bly depending on the experimental conditions and objec-
tives: the ΔCt, (PavrgE)Ct and (SavrgE)Ct models. ΔCt will
be preferred as an initial screening method when many
different sequences have to be screened quickly and eco-
nomically from few biological samples, but it will not
provide precise estimates, either relative or absolute.
(PavrgE)Ct and (SavrgE)Ct rely on an averaged efficiency
value, either performed from all data resulting from one
amplicon but irrespective of the biological sample or con-
dition, or performed over each sample and amplicon,
respectively. Thus, (PavrgE)Ct may be favoured when the
same gene or sequence is to be amplified repeatedly from
various biological treatments or specimens, or when fol-
lowing changes in the physiological or differentiation sta-
tus of a cell population over time, to obtain comparative
or relative estimates. In contrast, when absolute quantifi-
cation of DNA and highest precision is needed, and/or
when multiple sequences must be amplified from few
biological samples or conditions, (SavrgE)Ct will be the
method of choice, and the statistical analysis provided in
this study will allow the estimation of the dataset size
required to achieve a given accuracy.
Methods
Cell culture and cDNA preparation
Primary mouse fibroblast and NIH-3T3 mouse fibroblasts
were cultured in DMEM supplemented with 10% serum.
Cells were exposed to 100 pM TGF-β or to the ethanol car-
rier for 4 hours before RNA extraction. Total RNA was
extracted from confluent 75 cm2 culture dish (approx 2
million cells) using Trizol reagent (Invitrogen) according
to the manufacturer's protocol and resuspended in 20 μl
RNAse-free water. Reverse transcription was performed
with the GeneAmp Gold RNA PCR Core kit (PE Applied
Biosystem) using 5 μl (approx 2.5 μg) of RNA in a 25 μl
final volume using oligo-dT as a primer. The resulting
cDNA solution was diluted 10-fold in deionized water
and the solution thus obtained was considered as the
undiluted sample (1-fold dilution) for the qPCR measure-
ments. This final dilution step was found to be necessary
to prevent inhibitory effects on the PCR efficiency that
likely result from contaminant carry-over (data not
shown).
Experimental set of qPCR data
To statistically qualify the quantitative PCR process and to
evaluate the different models, we generated an experimen-
tal data set using 7 different amplicons. Expression of the
genes listed in Additional File 1 is controlled by a regula-
tory cascade elicited by the treatment of fibroblastic cells
with the Transforming Growth Factor-beta (TGF-β)
growth factor. mRNAs from cells that were either
untreated or induced by TGF-β were reverse transcribed to
cDNA and evaluated by quantitative PCR. These primer
pairs amplify portions of the Caveolin (Cav), Connective
Tissue Growth Factor (CTGF), Elastin (Eln), Fibronectin
(FN), Ribosomal protein L27, Perlecan (Perl) and Plas-
minogen Activator Inhibitor 1 (PAI-1) murine coding
sequences. The primers were designed using the Primer
Express 1.5a software (PE Applied Biosystem, Foster City,
CA, USA) to generate amplicon size ranging between 51
and 149 base pairs (Additional File 1), and amplicons
were located towards the 3' end of the coding sequence.
At least 4–8 distinct biological cDNA samples were used
in conjunction with each of the 7 different target genes
(amplicon). Each of these samples was serially diluted to
obtain 10-fold, 50-fold, 100-fold and for some samples
1000-fold dilutions from the undiluted (1-fold) sample.
Each of these dilutions was measured in 5 replicate PCR
reactions (4 replicates for the 1000× dilutions), using each
of the seven amplicons. This produced a data set of 704
reactions. The complete raw data set is given in the Addi-
tional File 2. Note that all sample were tested on the same
PCR plate for a given amplicon. Thus we only addressed
the intra-plate variability in this article and not the inter-
plate variability.BMC Bioinformatics 2007, 8:131 http://www.biomedcentral.com/1471-2105/8/131
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Quantitative PCR assays
SYBR green I technology was used for all quantitative PCR
reactions, which were assembled using the Eurogentec kit
RT-SN10-05 (Seraing, Belgium). Reactions were processed
with 5.9 μl of cDNA samples in 25 μl final volume. One
tip/well was used to distribute samples on the PCR plate
in order to increase reproducibility of the data. Primers
were all used at a final concentration of 100 nM and the
specificity of the amplification product was verified for
each reaction by examination of the corresponding disso-
ciation curve. All PCR reactions were performed on an ABI
Prism 7700 Sequence detector (PE Applied Biosystem,
Foster City, CA, USA). For all reactions, cycling conditions
were 95°C for 15 min (denaturation) and then 40 cycles
of 95°C 15 sec – 62°C 1 min. Data acquisitions were per-
formed with the SDS 1.9.1 software (PE Applied Biosys-
tem, Foster City, CA, USA). Baseline limits were set as
suggested by the manufacturer (i.e. at least two cycles
before the rise of the earliest amplification). Threshold
was set to lie in the middle of the exponential phase of the
amplification plot, so that efficiency values truly reflect
the reaction dynamic at the Ct. Unless otherwise noted in
the text, all efficiency values were determined using the
LinReg method [13]. Data resulting from reactions that
did not reach the threshold within the first 40 cycles (Ct =
40) were discarded from the analysis.
Equations
The full mathematical development of the following
equations can be found in the Additional File 6.
The exponential behaviour of DNA increase in the expo-
nential phase is described as follows:
Nc = N0 · Ec (1)
where Nc is the amount of PCR DNA product at cycle c; N0
the initial amount of target dsDNA and E the PCR reaction
efficiency.
When comparing distinct samples, the relative DNA con-
centrations can be calculated as:
where  RAB represents the initial concentration ratio of
sample A over B. Amplification efficiencies can be meas-
ured by taking the log of both side of Eq. 1, which gives a
linear function of log Nc = f(c):
log Nc = log N0 + c · log E (3)
where the ordinate to the origin gives a direct estimate of
N0, and the slope an estimate of the amplification effi-
ciency. But in fact it must be noted that qPCR measures
fluorescence that is proportional to the amount of DNA.
Therefore Eq. 3 really measures F0, with F0 = k·N0. But this
is not so important when measuring relative level of DNA
since the ratio of initial fluorescence is equal to the initial
ratio of target DNA.
When c = Ct, Eq. 3 can be rearranged as:
This expresses Ct as a linear function of (log N0), with a
slope  , allowing an estimation of a "mean"
efficiency over all samples:
Alternatively, sigmoid fitting of amplification can be per-
formed using Eq. 6
where a, b and x0 are fitting parameters and c is the cycle
number. The original amount of target DNA is given by:
Exponential fitting can also be performed but it requires
to first trim the data, removing values that are in phase III.
Then the remaining data can be fitted using:
Nc = exp[a · (c - x0)] (8)
where a and x0 are fitting parameters and c is the cycle
number. The initial amount of target DNA is given by:
N0 = exp[-a · x0]( 9 )
The propagation of error was determined using a Taylor
expansion to the first order. For the first part of the nor-
malized ratio (Eq. 2), this led to:
where  ΔRAB is the standard deviation of the ration of
amplicon A over amplicon B, and ΔA0 and ΔB0 the stand-
ard deviation of the initial amount of target DNA of
amplicon A and B.
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For the second part of the normalized ratio (Eq. 2), the
propagation of errors is described by:
Standard deviation on the efficiencies calculated with the
Serial dilution were evaluated from the standard deviation
of the slope of the regression using a Taylor expansion to
the first order for error propagation:
where ΔE is the standard deviation on the efficiency and
Δm is the standard deviation of the slope of the regression.
Standard deviation on the efficiencies measured with Lin-
Reg were obtained by averaging all efficiencies obtained
from the same data set used for the Serial dilution.
When comparing the expression of a gene in different
experimental conditions, the useful figure is the normal-
ized induction ratio:
where I1–2 is the ratio of the expression of the gene of
interest (induction) between condition 1 and condition 2
and RAB(i) is the normalized expression of the gene interest
(Eq. 2) in condition i (1 or 2). Note that Eq. 13 is valid
only if the gene used for the normalization (internal
standard) has an expression that is invariant with condi-
tion 1 and 2 [38]. Error on induction values is given by
See Additional File 6 for the full mathematical develop-
ment of Eq. 1 to Eq. 14.
Finally, the number of replicate needed to reach statistical
significance can be calculated as follows:
where n is the number of independent replicates, 
the normalized reduced value related to significance level
α of the statistical test (here α was set to 0.05, which cor-
responds to Z = 1.96) and CV the coefficient of variation
related to the measured inductions. Range is defined as the
largest acceptable error on the measure, and it is set arbi-
trarily by the experimenter. See Additional File 7 for the
full development of Eq. 15.
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